Federal Register / Vol. 65, No. 195 / Friday, October 6, 2000 / Notices 59849

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Kathy Cahill, Executive Secretary, Advisory

Committee to the Director, CDC, 1600 Clifton

Road, NE., M/S/ D–24, Atlanta, Georgia

30333. Telephone 404/639–7060.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: September 28, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–25710 Filed 10–5–00; 8:45 am]

BILLING CODE 4163–18–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Healthcare Infection Control Practices

Advisory Committee (HICPAC):

Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following meeting.

Name: Healthcare Infection Control

Practices Advisory Committee (Formerly

Hospital Infection Control Practices Advisory

Committee).

Times and Dates: 8:30 a.m.–5 p.m.,

November 6, 2000; 8:30 a.m.–4 p.m.,

November 7, 2000.

Place: Atlanta Marriott Century Center,

2000 Century Boulevard, NE, Atlanta,

Georgia 30345.

Status: Open to the public, limited only by

the space available.

Purpose: The Committee is charged with

providing advice and guidance to the

Secretary, the Assistant Secretary for Health,

the Director, CDC, and the Director, National

Center for Infectious Diseases (NCID),

regarding (1) the practice of hospital

infection control; (2) strategies for

surveillance, prevention, and control of

infections (e.g., nosocomial infections),

antimicrobial resistance, and related events

in settings where healthcare is provided; and

(3) periodic updating of guidelines and other

policy statements regarding prevention of

healthcare associated infections and

healthcare-related conditions.

Matters to be Discussed: Agenda items will

include a review of proposed revisions to the

Guideline for Prevention of Healthcareassociated Pneumonia, the Guideline for

Isolation Precautions in Hospitals, the

Guideline for Prevention of Intravascular

Device-related Infections, the Guideline for

Sterilization and Disinfection, the Guideline

for Hand Hygiene, and the Guideline for

Environmental Controls in Healthcare

Settings; a discussion of the status of

Staphylococcus aureus with Reduced

Susceptibility to Vancomycin (VISA) in the

United States; and updates on CDC activities

of interest to the committee, including

nosocomial tuberculosis control, the Federal

Action Plan for Antimicrobial Resistance,

and bioterrorism response in healthcare

facilities.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Michele L. Pearson, M.D., Executive

Secretary, HICPAC, Hospital Infections

Program, NCID, CDC, 1600 Clifton Road, NE,

M/S A–07, Atlanta, Georgia 30333, telephone

404/639–6439.

The Director, Management Analysis and

Services Office, has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: September 28, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–25685 Filed 10–5–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Interagency Committee on Smoking

and Health: Meeting

The National Center for Chronic

Disease Prevention and Health

Promotion (NCCDPHP) of the Centers

for Disease Control and Prevention

(CDC) announces the following meeting.

Name: Interagency Committee on Smoking

and Health.

Date and Time: 9 a.m.–1 p.m. October 26,

2000.

Place: Secretary’s Conference Room

(Stonehenge) Hubert H. Humphrey Building,

200 Independence Avenue, SW, 6th Floor,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available. Those who wish to

attend are encouraged to register with the

contact person listed below. If you will

require a sign language interpreter, or have

other special needs, please notify the contact

person by 4:30 E.S.T. on October 20, 2000.

Purpose: The Interagency Committee on

Smoking and Health advises the Secretary,

Department of Health and Human Services,

and the Assistant Secretary for Health in the:

(a) Coordination of all research and

education programs and other activities

within the Department and with other

federal, state, local and private agencies, and

(b) establishment and maintenance of liaison

with appropriate private entities, federal

agencies, and state and local public health

agencies with respect to smoking and health

activities.

Matters to be Discussed: The agenda will

focus on the Framework Convention on

Tobacco Control.

Contact Person for More Information:

Substantive program information as well as

summaries of the meeting and roster of

committee members may be obtained from

the Internet (www.cdc.gov/tobacco) in midNovember or from Ms. Monica L. Swann,

Interagency Committee on Smoking and

Health, Office on Smoking and Health,

NCCDPHP, CDC, 200 Independence Avenue,

SW, Room 317B, Washington, DC, 20201,

telephone (202) 205–8500.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: September 28, 2000.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 00–25689 Filed 10–5–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[Docket No. 00N–1534]

Agency Information Collection

Activities; Proposed Collection;

Comment Request; Year 2000

Continuation of National Surveys of

Prescription Drug Information

Provided to Patients

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing an

opportunity for public comment on the

proposed collection of certain

information by the agency. Under the

Paperwork Reduction Act of 1995 (the

PRA), Federal agencies are required to

publish notice in the Federal Register

concerning each proposed collection of

information, and to allow 60 days for

public comment in response to the

notice. This notice solicits comments on

a national tracking survey, conducted

every 2 years, of prescription drug

information received by patients.

DATES: Submit written or electronic

comments on the collection of

information by December 5, 2000.